A study to collect health data in lung disease
Part of Lungs & breathing clinical trials.
This study follows adults who have suspected diffuse lung disease (abnormal changes in multiple areas of the lungs) and collects health information over time. It may help doctors better understand these lung conditions and how they progress.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 21 years old or older
- You must have suspected diffuse lung disease
- Your chest scans should show changes in multiple areas of the lungs
- There are no stated other exclusion rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study enrolls adults with chronic lung conditions like COPD, cystic fibrosis, bronchiectasis, or interstitial lung disease. It’s designed to learn more about these illnesses and to develop better ways to study or improve care.
This study follows people with chronic airway diseases like COPD, asthma, or bronchiectasis who were recently hospitalized for a worsening of their condition. It aims to understand how these diseases affect overall health and other medical problems over time.
This study aims to improve how doctors diagnose and classify lung conditions that affect both the air sacs and airways, such as COPD and pulmonary fibrosis. By participating, you may help advance medical knowledge and better understand your own condition.
This study tracks lung function over time in people with chronic lung disease. It helps doctors understand how lung health changes and may improve future care.
This study looks at how young adults' lungs work over time. It is a research visit where you'll complete breathing and other health tests to help understand lung health in people aged 25–35.
This study follows adults with heart-and-lung health information over time to understand how these conditions change. It may help researchers find patterns that could guide better care in the future.
Hear when a new Diffuse Parenchymal Lung Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.